Notably, TRM scored higher than models such as Google’s Gemini 2.5 Pro (37%), OpenAI’s o3-mini-high (34.5%), and DeepSeek-R1 ...

Discover the surprising behaviors of AI systems left alone, from project managers to philosophers, shedding light on AI ...

If it can bounce back and generate solid returns in the next five years, now is about as good a time as any to invest in the ...

The trend of AI researchers developing new, small open source generative models that outperform far larger, proprietary peers continued this week with yet another staggering advancement. Alexia ...

Recursive digital selves underpin targeted advertising, predictive policing, and workplace monitoring. In each case, the ...

Recursion Pharmaceuticals (RXRX) ended the recent trading session at $4.98, demonstrating a +1.32% change from the preceding day's closing price. The stock's change was more than the S&P 500's daily ...

How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...

I don’t know. It’s been such a dog. It’s been a dog, we had them on, twice the price. It’s done absolutely nothing. I need to ...

In this article, we will be taking a look at the Top 10 AI-Powered Biotech Stocks to Buy Now. Recursion Pharmaceuticals, Inc. is one of them. Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX), a ...